8-K

Company

Pelthos Therapeutics Inc.

Filed

January 2, 2026

Period of Report

December 23, 2025

Accession Number

0001753926-26-000010

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →